As Japan becomes one of the world’s most rapidly aging societies, adult vaccination is emerging as a critical yet underutilized tool for protecting health, sustaining productivity, and strengthening economic resilience. The report highlights how adult vaccines can reduce hospitalizations, improve productivity among older workers, and strengthen the sustainability of Japan’s healthcare system in a rapidly…

In February 2026, GCOA released an outcomes report from the OECD-GCOA workshop. The report highlights the importance of integrating prevention and workforce wellbeing into core economic and labor policy, with health and wealth viewed as two sides of the same coin. Key calls to action include embedding healthy workforce aging into national economic strategies; scaling…

The central narrative lays out three pillars that are essential to the new prevention paradigm for the 21st century, centered around adult immunization: Innovative Medicines, Vaccines and Models: Scaling Breakthroughs to Unlock Prevention Resilient Health Systems: Creating Readiness for a Super-Aging Society Smart Aging Investments: Maximizing the Full Value of Longevity for Workforces and Communities 

In December 2024, IQVIA released a new white paper, developed in collaboration with GSK and GCOA, examining the significant economic and clinical burden of Respiratory Syncytial Virus (RSV) in older adults (age ≥60 years) across select high-income APEC countries, including China, Japan, South Korea, Canada, Singapore, New Zealand, Australia, Hong Kong, and Taiwan. The study…

This new GCOA paper, launched ahead of Silver Economy Forum 2024, examines how industry leaders are creating business value, engaging their workforce, improving productivity and economic value, and advancing top private-sector priorities by taking action on preventive health for their employees through employee benefits and policies, such as supporting access to adult immunization, mental health…